Zobrazeno 1 - 10
of 323
pro vyhledávání: '"Paul H. Plotz"'
Autor:
Wolfgang L. Gross
Publikováno v:
Zeitschrift f�r Rheumatologie. 62:101-101
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9db4da7d3270105e577d21285f0a6b69
https://doi.org/10.1007/s00393-003-0506-y
https://doi.org/10.1007/s00393-003-0506-y
Autor:
Adam Schiffenbauer, JoAnn M. Mican, Laura B Lewandowski, Soka J. Moses, James D. Katz, Mosaka P. Fallah, Paul H. Plotz
Publikováno v:
Clinical Rheumatology. 39:689-696
Liberia has no rheumatology providers for the nation's 4.7 million people. We proposed a short course format rheumatology curriculum to educate Liberian providers as an initial step in providing graduate medical education in musculoskeletal health.A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4423241827f98f7f19287efc92716c54
https://doi.org/10.1007/s10067-019-04817-6
https://doi.org/10.1007/s10067-019-04817-6
Myositis Autoantigen Expression Correlates With Muscle Regeneration but Not Autoantibody Specificity
Autor:
David R. Amici, José C. Milisenda, Assia Derfoul, Andrea M. Corse, Maria Casal-Dominguez, Lisa Christopher-Stine, Andrew L. Mammen, Julie J. Paik, Jemima Albayda, Thomas E. Lloyd, Richard M Yeker, Iago Pinal-Fernandez, Albert Selva-O'Callaghan, Cassie A. Parks, Katherine Pak, Paul H. Plotz, Josep M. Grau-Junyent
Publikováno v:
Arthritis Rheumatol
Objective Although more than a dozen myositis-specific autoantibodies (MSAs) have been identified, most patients with myositis are positive for a single MSA. The specific overexpression of a given myositis autoantigen in myositis muscle has been prop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e7b253a972ac22b6bdcbfc159ac79d4
https://doi.org/10.1002/art.40883
https://doi.org/10.1002/art.40883
Autor:
Shoichi Takikita, Cynthia Schreiner, Rebecca Baum, Tao Xie, Evelyn Ralston, Paul H Plotz, Nina Raben
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e15239 (2010)
PGC-1α is a transcriptional co-activator that plays a central role in the regulation of energy metabolism. Our interest in this protein was driven by its ability to promote muscle remodeling. Conversion from fast glycolytic to slow oxidative fibers
Externí odkaz:
https://doaj.org/article/29f1fd6a68f84f48a5f2b0ac27a9d057
Autor:
Sean McNish, Christopher E Collins, Victoria K. Shanmugam, Paul H. Plotz, Joseph D. Croft, Sonia D. Silinsky Krupnikova
Publikováno v:
International Journal of Rheumatic Diseases. 20:2258-2261
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0961a5eaa07285190720552003435a8
https://doi.org/10.1111/1756-185x.13039
https://doi.org/10.1111/1756-185x.13039
Autor:
Julie Paik, Lisa Christopher-Stine, Andrea M. Corse, José C. Milisenda, Assia Derfoul, Maria Casal-Dominguez, Frederick W. Miller, Jemima Albayda, Katherine Pak, Andrew L. Mammen, Thomas E. Lloyd, Albert Selva-O'Callaghan, Josep M. Grau-Junyent, Iago Pinal-Fernandez, Paul H. Plotz
Publikováno v:
Neurology
ObjectiveActivation of the type 1 interferon (IFN1) pathway is a prominent feature of dermatomyositis (DM) muscle and may play a role in the pathogenesis of this disease. However, the relevance of the IFN1 pathway in patients with other types of myos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99985ba5e58fb0b6ab8965668a7b4c22
https://europepmc.org/articles/PMC6808530/
https://europepmc.org/articles/PMC6808530/
Autor:
Gross, W. L.
Publikováno v:
Zeitschrift für Rheumatologie; April 2003, Vol. 62 Issue: 2 p101-101, 1p
Autor:
Menachem Sadeh, Ron Dabby, Esther Leshinsky-Silver, Peter Hackman, Bjarne Udd, David Hilton-Jones, Paul H. Plotz, Anna Vihola
Publikováno v:
Journal of the Neurological Sciences. 351:120-123
Rarely, inflammation can be present in genetic myopathies, such as dysferlinopathies, facioscapulohumeral muscular dystrophy and GNE-myopathy (hereditary inclusion body myopathy). This may lead to erroneous initial diagnosis and unnecessary therapy w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40b69ebc6cc8f06d51fc234e30331b64
https://doi.org/10.1016/j.jns.2015.03.001
https://doi.org/10.1016/j.jns.2015.03.001
Autor:
Imelda Victoria Cabalar, Christine Castro, Adam Schiffenbauer, Angelina Pokrovnichka, Michael O. Harris-Love, Frederick W. Miller, Paul H. Plotz, Mark F. Gourley, Joseph A. Shrader, Sara Faghihi-Kashani, Galen O. Joe, Megha Garg
To investigate in a pilot study the safety and efficacy of infliximab in patients with refractory dermatomyositis (DM) and polymyositis (PM).A randomized, double-blind, placebo-controlled trial including subjects with active DM or PM. Participants ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6de8a35d34831b3e1474a7c916ef6c91
https://europepmc.org/articles/PMC6208161/
https://europepmc.org/articles/PMC6208161/
Autor:
Paul H. Plotz
Publikováno v:
Arthritis & Rheumatology. 66:2915-2920
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::333658121f7b3403299d1374db2411bc
https://doi.org/10.1002/art.38796
https://doi.org/10.1002/art.38796